Open Philanthropy recommended a grant of $2,531,000 over three years to Stanford University to support work led by Professor Jeffrey Glenn to test an antiviral drug candidate against COVID-19 and a number of other viruses. Professor Glenn plans to use this funding to conduct toxicity and efficacy tests and to have a supply of the drug synthesized for use in future trials.
This follows Open Philanthropy's February 2020 support and falls within its work on scientific research, specifically within its interest in science supporting biosecurity and pandemic preparedness.